AN INTERMEDIATE ALEMTUZUMAB SCHEDULE REDUCES THE INCIDENCE OF MIXED CHIMERISM FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OF PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DISORDERS
PEDIATRIC BLOOD & CANCER(2014)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined